Q32 Bio (QTTB) Cash from Investing Activities (QoQ) (2017 - 2024)
Q32 Bio (QTTB) Cash from Investing Activities (QoQ) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -100.02% |
| Sep 30, 2024 | 0.55% |
| Jun 30, 2024 | 10,093.81% |
| Sep 30, 2023 | -200.00% |
| Jun 30, 2023 | 120.00% |
| Mar 31, 2023 | -100.03% |
| Dec 31, 2022 | 116.62% |
| Sep 30, 2022 | -161.59% |
| Jun 30, 2022 | -124.58% |
| Mar 31, 2022 | 285.50% |
| Dec 31, 2021 | 865.10% |
| Sep 30, 2021 | 132.93% |
| Jun 30, 2021 | 83.88% |
| Mar 31, 2021 | -8,825.13% |
| Dec 31, 2020 | -102.46% |
| Sep 30, 2020 | -25.31% |
| Jun 30, 2020 | -54.77% |
| Mar 31, 2020 | 674.21% |
| Dec 31, 2019 | -52.45% |
| Sep 30, 2019 | 65.70% |